about
Positive effects of voluntary running on metabolic syndrome-related disorders in non-obese hereditary hypertriacylglycerolemic ratsPioglitazone induces de novo ceramide synthesis in the rat heartAMP-activated protein kinase α2 subunit is required for the preservation of hepatic insulin sensitivity by n-3 polyunsaturated fatty acids.Plasma gelsolin modulates cellular response to sphingosine 1-phosphate.Effects of inhibition of serine palmitoyltransferase (SPT) and sphingosine kinase 1 (SphK1) on palmitate induced insulin resistance in L6 myotubesNew evidence for the role of ceramide in the development of hepatic insulin resistance.Sources, metabolism, and regulation of circulating sphingosine-1-phosphateMitochondrial substrate availability and its role in lipid-induced insulin resistance and proinflammatory signaling in skeletal muscle.Training Does Not Alter Muscle Ceramide and Diacylglycerol in Offsprings of Type 2 Diabetic Patients Despite Improved Insulin Sensitivity.Myocardium of type 2 diabetic and obese patients is characterized by alterations in sphingolipid metabolic enzymes but not by accumulation of ceramide.Heart sphingolipids in health and disease.Exercise increases sphingoid base-1-phosphate levels in human blood and skeletal muscle in a time- and intensity-dependent manner.Aerobic training in rats increases skeletal muscle sphingomyelinase and serine palmitoyltransferase activity, while decreasing ceramidase activity.Change in blood gelsolin concentration in response to physical exercise.Effect of high fat diet enriched with unsaturated and diet rich in saturated fatty acids on sphingolipid metabolism in rat skeletal muscle.Altered sphingolipid metabolism in human endometrial cancer.Sustained decrease in plasma sphingosine-1-phosphate concentration and its accumulation in blood cells in acute myocardial infarction.Effect of exercise duration on the key pathways of ceramide metabolism in rat skeletal muscles.Ultramarathon run markedly reduces plasma sphingosine-1-phosphate concentration.n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet.Effect of metformin on bioactive lipid metabolism in insulin-resistant muscle.Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity.Bezafibrate decreases growth stimulatory action of the sphingomyelin signaling pathway in regenerating rat liver.Effect of exercise duration on ceramide metabolism in the rat heart.Liver X Receptor Agonist TO901317 Prevents Diacylglycerols Accumulation in the Heart of Streptozotocin-Diabetic Rats.LXR agonist T0901317-Induced hyperlipidemia does not lead to lipid accumulation in the rat heart.Endurance training selectively increases high-density lipoprotein-bound sphingosine-1-phosphate in the plasma.Low expression of IL-18 and IL-18 receptor in human skeletal muscle is associated with systemic and intramuscular lipid metabolism-Role of HIV lipodystrophy.Arteriovenous Sphingosine-1-Phosphate Differences Across Selected Organs of the Rat.Insulin-sensitizing effect of LXR agonist T0901317 in high-fat fed rats is associated with restored muscle GLUT4 expression and insulin-stimulated AS160 phosphorylation.Dose-dependent effect of aspirin on the level of sphingolipids in human blood.Myocardial lipid profiling during time course of high fat diet and its relationship to the expression of fatty acid transporters.Partial hepatectomy activates production of the pro-mitotic intermediates of the sphingomyelin signal transduction pathway in the rat liverArterio-venous difference in sphingosine-1-phosphate concentration in plasma and lipoproteins in hepatic, pulmonary and leg circulationMuscle-Saturated Bioactive Lipids Are Increased with Aging and Influenced by High-Intensity Interval TrainingAssessment of the Main Compounds of the Lipolytic System in Treadmill Running Rats: Different Response Patterns between the Right and Left Ventricle.Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetesDecreased free sphingoid base concentration in the plasma of patients with chronic systolic heart failureCeramide metabolism is affected by obesity and diabetes in human adipose tissueReduction of ceramide de novo synthesis in solid tissues changes sphingolipid levels in rat plasma, erythrocytes and platelets
P50
Q28545267-255D4CD0-98C5-4876-B707-24034D15CB06Q28579239-E8F24B88-B7DC-4670-BA0D-2BA8E77313B1Q34237595-05224C7C-ED95-4317-941E-1856B6E404A4Q34426423-182F84C8-915A-4893-B0F2-84B54CDDED9DQ35078615-070BEBBD-0638-4610-9B52-7E39D471D574Q35551917-3D3ABEC5-8F8C-4289-8D88-1753010C1966Q35776618-C3833D49-1181-4224-B530-F48317385E91Q37193277-607E8EBD-5DE0-4361-9AB6-9522710F110FQ37335290-C02D2ED7-068F-4A4C-B74C-174E53A440C2Q37463334-B7C6028C-3D0E-42FE-81A8-5AEAD66B587BQ37930545-02FDBC9B-2096-4807-A047-53A8E08F57ADQ40022506-961B3155-5AC5-4AF3-818E-B9D2C66E87A3Q41808679-B7FE1C61-F82E-4878-BFA2-A44CFCA3CC73Q42003996-144E4CBE-3A22-42C2-9AC8-242B340F55BEQ43010075-601D134B-01CC-4445-AAD1-C06F09DBE046Q43131360-E7F9CCA7-E7B8-452D-8F8E-6E4314D75A69Q44999460-F325F9E4-C219-49C0-B9E5-B28CB562938CQ45340419-F86DA498-FDB0-451A-9E42-E544F73E886FQ45827694-5CD5CDB2-91ED-40FA-8912-299012F25F44Q46092511-C0FC176F-9C08-44BA-A38C-C5C37D93C520Q46363785-B8788C49-D7A5-420D-8A81-5C51AA0A14B7Q46610480-0D2EDD4D-A58D-4829-A182-0B8A821BB3A3Q46892492-2FFEA81D-F050-47C3-AADC-14960C8FC656Q46923508-DB012082-B050-4160-A61D-3F2AC6930ACDQ47415387-2FCAC066-1438-4309-B340-51C660973190Q47751655-6566925F-87C8-4A1A-9B05-BEA4A572BCD0Q48158764-3247D3C3-A16F-4381-AA16-E5C651BBB581Q48226767-4008EB31-E8D2-4631-9A01-BE97283415ACQ50116552-7DC27D9B-0381-4B42-8168-96B127EEB429Q50473793-13E5BEB5-1ADB-41E0-9EB1-DA65E473EB4CQ53087596-6D697AD4-F666-4D7F-87DE-6C379A9CCFA0Q53816630-350AACC1-8F74-43D1-B156-8A6387FF2EDCQ62034254-4CA7392F-C681-46FD-BB5C-636175CED12DQ63805087-CF2D0CB3-AC40-4B96-A23F-DCF8BB6BB5BFQ64103280-DA2D9982-6A03-418B-B7FB-22A8F46AC86DQ64944718-E0D191F1-FB03-4D3D-B952-70FD2A3C53E2Q80854696-BCCCC49A-CDF5-41A2-B025-2BCC5475D285Q83379430-7D1D6EA8-93F6-46A1-BA9E-D4B833C357EDQ83711035-39CDC5A9-3D8D-43E1-93A0-2EBDA1EA38A3Q86597223-692C9E35-90BC-41BA-A0F7-F84ED6EE3400
P50
description
polski biolog, (biologia medyczna)
@pl
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marcin Baranowski
@ast
Marcin Baranowski
@en
Marcin Baranowski
@es
Marcin Baranowski
@nl
Marcin Baranowski
@pl
type
label
Marcin Baranowski
@ast
Marcin Baranowski
@en
Marcin Baranowski
@es
Marcin Baranowski
@nl
Marcin Baranowski
@pl
prefLabel
Marcin Baranowski
@ast
Marcin Baranowski
@en
Marcin Baranowski
@es
Marcin Baranowski
@nl
Marcin Baranowski
@pl
P106
P1153
22133657400
P1559
Marcin Baranowski
@pl
P21
P31
P3124
P496
0000-0002-3714-5815